 SOUTH SAN FRANCISCO, Calif., Sept. 20, 2021 GLOBE NEWSWIRE -- Aligos Therapeutics, Inc. Nasdaq: ALGS, a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in viral and liver diseases, today announced that Lawrence M. Blatt, Ph.D., MBA, Chairman and CEO of Aligos, will present at the Cantor Virtual Global Healthcare Conference being held September 27-30, 2021. 